ADVERTISEMENT
ADVERTISEMENT

Roy Silverstein

The Scientist THE SCIENTIST® The Newspaper for the Life Sciences Professional "Reading THE SCIENTIST gives me rapid insight into fast-breaking developments in all areas of science while keeping me abreast of important national political and economic trends critically important to the future of clinical research." ROY SILVERSTEIN, past president, American Federation for Clinical Research, Thorofare, N.J.; professor of medicine, Cornell University Medical College, New York As head of the

The Scientist Staff

The Scientist


THE SCIENTIST®
The Newspaper for the Life Sciences Professional
"Reading THE SCIENTIST gives me rapid insight into fast-breaking developments in all areas of science while keeping me abreast of important national political and economic trends critically important to the future of clinical research."

ROY SILVERSTEIN, past president, American Federation for Clinical Research, Thorofare, N.J.; professor of medicine, Cornell University Medical College, New York

As head of the division of oncology/hematology at the New York Hospital-Cornell Medical Center, Roy Silverstein is deeply involved in vascular studies examining the interplay between thrombosis and arteriosclerosis.

The concept that abnormal activation of endothelial cells may contribute to vascular disease and may be caused by a variety of agents not previously examined has been a major focus of his research. "We and our collaborators have shown that herpes virus can activate endothelial cells, and that antibodies from patients with lupus can...

Interested in reading more?

Become a Member of

Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?
ADVERTISEMENT